Dr. Briana Patterson, MD

NPI: 1013194513
Total Payments
$4,965
2022 Payments
$21.73
Companies
4
Transactions
9

Payment Breakdown by Category

Travel$3,562 (71.8%)
Research$1,268 (25.5%)
Food & Beverage$134.01 (2.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $3,562 2 71.8%
Unspecified $1,268 2 25.5%
Food and Beverage $134.01 5 2.7%

Payments by Type

General
$3,697
7 transactions
Research
$1,268
2 transactions

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $3,604 3 $0 (2019)
Novartis Pharmaceuticals Corporation $1,268 2 $0 (2020)
Novo Nordisk Inc $66.95 3 $0 (2022)
Horizon Pharma plc $25.12 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $21.73 1 Novo Nordisk Inc ($21.73)
2021 $20.71 1 Novo Nordisk Inc ($20.71)
2020 $1,268 2 Novartis Pharmaceuticals Corporation ($1,268)
2019 $3,587 3 E.R. Squibb & Sons, L.L.C. ($3,562)
2017 $67.06 2 E.R. Squibb & Sons, L.L.C. ($41.94)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/17/2022 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $21.73 General
Category: Growth Hormone
10/06/2021 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $20.71 General
Category: Growth Hormone
09/30/2020 Novartis Pharmaceuticals Corporation TASIGNA (Drug) In-kind items and services $1,125.00 Research
Study: RESEARCH RELATED PUBLICATIONS SUPPORT • Category: HEMATOLOGY
03/01/2020 Novartis Pharmaceuticals Corporation TASIGNA (Drug) In-kind items and services $143.00 Research
Study: RESEARCH RELATED PUBLICATIONS SUPPORT • Category: HEMATOLOGY
08/13/2019 Novo Nordisk Inc Norditropin (Drug) Food and Beverage In-kind items and services $24.51 General
Category: Growth Hormone
06/13/2019 E.R. Squibb & Sons, L.L.C. SPRYCEL (Drug) Travel and Lodging Cash or cash equivalent $2,011.73 General
Category: Oncology
06/13/2019 E.R. Squibb & Sons, L.L.C. SPRYCEL (Drug) Travel and Lodging Cash or cash equivalent $1,550.76 General
Category: Oncology
12/09/2017 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $41.94 General
07/21/2017 Horizon Pharma plc RAVICTI (Drug) Food and Beverage In-kind items and services $25.12 General
Category: RAVICTI

Research Studies & Clinical Trials

Study Name Company Amount Records
RESEARCH RELATED PUBLICATIONS SUPPORT Novartis Pharmaceuticals Corporation $1,268 2

About Dr. Briana Patterson, MD

Dr. Briana Patterson, MD is a Pediatrics healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013194513.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Briana Patterson, MD has received a total of $4,965 in payments from pharmaceutical and medical device companies, with $21.73 received in 2022. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($3,562).

Practice Information

  • Specialty Pediatrics
  • Location Atlanta, GA
  • Active Since 01/28/2008
  • Last Updated 01/28/2008
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1013194513

Products in Payments

  • SPRYCEL (Drug) $3,562
  • TASIGNA (Drug) $1,268
  • Norditropin (Biological) $42.44
  • RAVICTI (Drug) $25.12
  • Norditropin (Drug) $24.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Atlanta